Condition: Type 2 Diabetes Mellitus · Sponsor: Insulet Corporation
A multi-center, 26-week randomized controlled trial (RCT) to evaluate the safety and efficacy of the fully closed loop Omnipod M System in adults with type 2 diabetes using basal/bolus insulin therapy or basal-only insulin therapy, with the primary endpoint after 15 weeks and secondary analysis at 26 weeks; followed by an extension phase after completion of the 26-week trial where the Intervention group will continue to use Omnipod M and the Control group will crossover to use Omnipod M for 26 weeks
This description comes directly from the study's public registry record.
Trang Ly, MBBS, PhD · 978-600-7000 · APClinical@insulet.com
Bonnie Dumais, RN · 978-600-7000 · APClinical@insulet.com
Always discuss trial participation with your own doctor first.
| University of Southern California | Los Angeles, California, United States | Recruiting |
| HOAG | Newport Beach, California, United States | Recruiting |
| Sansum Diabetes Research Institute | Santa Barbara, California, United States | Recruiting |
| Touro University California | Vallejo, California, United States | Recruiting |
| University of Colorado Denver | Denver, Colorado, United States | Recruiting |
| University of South Florida | Tampa, Florida, United States | Active Not Recruiting |
| Metabolic Research Institute | West Palm Beach, Florida, United States | Recruiting |
| EMORY | Atlanta, Georgia, United States | Recruiting |
| Atlanta Diabetes Associates | Atlanta, Georgia, United States | Recruiting |
| Endocrine Research Solutions, Inc. | Rosewell, Georgia, United States | Recruiting |
| Rocky Mountain Diabetes | Idaho Falls, Idaho, United States | Recruiting |
| Northwestern University | Chicago, Illinois, United States | Recruiting |
+ 15 more locations — full list on the registry record.
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.